Intestinal GPR128 deficiency protects against acetaminophen-induced liver injury through the gut-liver axis.
Intestinal GPR128 deficiency protects against AILI through a gut-liver axis involving goblet cell-associated A. muciniphila, microbial β-galactosidase, dietary GA, and the HSP90α-CBFβ/RUNX1-UPP1 pathway, identifying this cascade as a potential therapeutic target for APAP-induced liver injury.